Quest Diagnostics, Inc’s recent filing unveils that its SVP & General Counsel PREVOZNIK MICHAEL E unloaded Company’s shares for reported $5.73 million on Nov 29 ’24. In the deal valued at $163.07 per share,35,146 shares were sold. As a result of this transaction, PREVOZNIK MICHAEL E now holds 38,478 shares worth roughly $5.87 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Doherty Catherine T. sold 33,103 shares, generating $5,395,484 in total proceeds. Upon selling the shares at $162.99, the EVP, Regional Businesses now owns 68,412 shares.
Before that, PREVOZNIK MICHAEL E bought 35,146 shares. Quest Diagnostics, Inc shares valued at $5,731,302 were divested by the Officer at a price of $163.07 per share.
A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who increased its forecast for the stock in late October from “a Neutral” to “an Outperform”. Citigroup revised its rating on July 10, 2024. It rated DGX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of DGX
On Monday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock fall -1.52% to $152.65. Over the last five days, the stock has lost -3.51%. Quest Diagnostics, Inc shares have risen nearly 10.71% since the year began. Nevertheless, the stocks have risen 11.21% over the past one year. While a 52-week high of $165.32 was reached on 11/25/24, a 52-week low of $123.04 was recorded on 02/01/24. SMA at 50 days reached $156.35, while 200 days put it at $145.28.
Levels Of Support And Resistance For DGX Stock
The 24-hour chart illustrates a support level at 151.39, which if violated will result in even more drops to 150.12. On the upside, there is a resistance level at 154.71. A further resistance level may holdings at 156.76. The Relative Strength Index (RSI) on the 14-day chart is 33.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.98%. Stochastics %K at 4.66% indicates the stock is a buying.
How much short interest is there in Quest Diagnostics, Inc?
A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2024-11-29, dropping by -0.34 million shares to a total of 2.04 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 2.38 million shares. There was a decline of -16.85%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 26, 2024 when Leerink Partners began covering the stock and recommended ‘”a Market perform”‘ rating along with a $135 price target.
